IL142696A0 - Crystal modification a of 8-cyano-1-cyclopropyl-7-(1s,6s,-2, 8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid - Google Patents

Crystal modification a of 8-cyano-1-cyclopropyl-7-(1s,6s,-2, 8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid

Info

Publication number
IL142696A0
IL142696A0 IL14269699A IL14269699A IL142696A0 IL 142696 A0 IL142696 A0 IL 142696A0 IL 14269699 A IL14269699 A IL 14269699A IL 14269699 A IL14269699 A IL 14269699A IL 142696 A0 IL142696 A0 IL 142696A0
Authority
IL
Israel
Prior art keywords
nonan
diazabicyclo
cyclopropyl
dihydro
oxo
Prior art date
Application number
IL14269699A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL142696A0 publication Critical patent/IL142696A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL14269699A 1998-11-25 1999-11-15 Crystal modification a of 8-cyano-1-cyclopropyl-7-(1s,6s,-2, 8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid IL142696A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854356A DE19854356A1 (de) 1998-11-25 1998-11-25 Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
PCT/EP1999/008775 WO2000031075A1 (de) 1998-11-25 1999-11-15 Kristallmodifikation a von 8-cyan-1- cyclopropyl-7- (1s,6s-2,8 -diazabicyclo -[4.3.0]nonan -8-yl)-6- fluor-1,4- dihydro-4- oxo-3- chinolincarbonsäure

Publications (1)

Publication Number Publication Date
IL142696A0 true IL142696A0 (en) 2002-03-10

Family

ID=7888960

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14269699A IL142696A0 (en) 1998-11-25 1999-11-15 Crystal modification a of 8-cyano-1-cyclopropyl-7-(1s,6s,-2, 8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
IL142696A IL142696A (en) 1998-11-25 2001-04-19 Crystalline form A of acid 8 - cyano - 1 - cyclopropyl - 7 - (S1, S6 - 2, 8 diazabicyclo [0.3.4] nonane - 8 - il 6 - fluoro - 1,4 - dihydrate and 4 - oxo - 3 Quinolinecarboxylic acid and pharmaceuticals containing it

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142696A IL142696A (en) 1998-11-25 2001-04-19 Crystalline form A of acid 8 - cyano - 1 - cyclopropyl - 7 - (S1, S6 - 2, 8 diazabicyclo [0.3.4] nonane - 8 - il 6 - fluoro - 1,4 - dihydrate and 4 - oxo - 3 Quinolinecarboxylic acid and pharmaceuticals containing it

Country Status (27)

Country Link
US (1) US6436955B1 (pt)
EP (1) EP1133496B1 (pt)
JP (1) JP2002530406A (pt)
KR (1) KR100740947B1 (pt)
CN (1) CN1135230C (pt)
AR (1) AR031216A1 (pt)
AT (1) ATE264858T1 (pt)
AU (1) AU763883B2 (pt)
BR (1) BRPI9915669B8 (pt)
CA (1) CA2351712C (pt)
CZ (1) CZ300016B6 (pt)
DE (2) DE19854356A1 (pt)
DK (1) DK1133496T3 (pt)
ES (1) ES2217843T3 (pt)
HK (1) HK1042703B (pt)
HU (1) HUP0104465A3 (pt)
IL (2) IL142696A0 (pt)
NO (1) NO318066B1 (pt)
NZ (1) NZ511861A (pt)
PL (1) PL196085B1 (pt)
PT (1) PT1133496E (pt)
RU (1) RU2247122C2 (pt)
SK (1) SK285540B6 (pt)
TR (1) TR200101438T2 (pt)
TW (1) TW576835B (pt)
UA (1) UA67874C2 (pt)
WO (1) WO2000031075A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19854355A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US10780168B2 (en) 2017-02-13 2020-09-22 Bayer Animal Health Gmbh Liquid composition containing pradofloxacin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2676521B2 (ja) * 1988-03-22 1997-11-17 北陸製薬株式会社 キノロンカルボン酸化合物ｉ型結晶の製造法
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
EP0790992A1 (en) 1994-11-18 1997-08-27 PHARMACIA & UPJOHN COMPANY A new physically stable solid form of a fluoroquinolone
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
TR199801493T2 (xx) * 1996-02-23 1998-10-21 Bayer Aktiengesellschaft �ste�e g�re ikame edilen 8-siyano-1-siklopropil-7-(2,8-diazabisiklo(4.3.0) nonan-8il)-6-fl�oro-1,4-dihidro-4-okso-3-kinolinkarboksilik asitler ve bunlar�n t�revleri.
DE19633805A1 (de) 1996-02-23 1997-08-28 Bayer Ag Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
DE19854355A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure

Also Published As

Publication number Publication date
AR031216A1 (es) 2003-09-17
DE59909262D1 (de) 2004-05-27
EP1133496B1 (de) 2004-04-21
PL347786A1 (en) 2002-04-22
UA67874C2 (uk) 2004-07-15
KR20010080926A (ko) 2001-08-25
TW576835B (en) 2004-02-21
CN1135230C (zh) 2004-01-21
AU763883B2 (en) 2003-07-31
HUP0104465A3 (en) 2002-12-28
AU1553300A (en) 2000-06-13
PT1133496E (pt) 2004-08-31
ATE264858T1 (de) 2004-05-15
TR200101438T2 (tr) 2001-10-22
HK1042703B (zh) 2004-12-03
CZ20011858A3 (cs) 2001-09-12
HK1042703A1 (en) 2002-08-23
KR100740947B1 (ko) 2007-07-19
JP2002530406A (ja) 2002-09-17
SK6822001A3 (en) 2001-12-03
BRPI9915669B1 (pt) 2017-07-04
DE19854356A1 (de) 2000-05-31
NO20012460L (no) 2001-05-18
DK1133496T3 (da) 2004-08-09
BRPI9915669B8 (pt) 2021-07-06
BRPI9915669A (pt) 2001-08-14
US6436955B1 (en) 2002-08-20
NO20012460D0 (no) 2001-05-18
WO2000031075A1 (de) 2000-06-02
IL142696A (en) 2006-04-10
NZ511861A (en) 2002-12-20
PL196085B1 (pl) 2007-12-31
SK285540B6 (sk) 2007-03-01
CA2351712A1 (en) 2000-06-02
CZ300016B6 (cs) 2009-01-14
CN1328558A (zh) 2001-12-26
NO318066B1 (no) 2005-01-31
HUP0104465A2 (hu) 2002-04-29
CA2351712C (en) 2011-07-12
RU2247122C2 (ru) 2005-02-27
EP1133496A1 (de) 2001-09-19
ES2217843T3 (es) 2004-11-01

Similar Documents

Publication Publication Date Title
HK1039939A1 (zh) α-取代羧酸衍生物
AP9901649A0 (en) Salt of naphthyridine carboxylic acid derivatives
IL142695A0 (en) Crystal modification b of 8-cyano-1-cyclopropyl-7-(1s,6s,-2, 8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
IL148738A0 (en) Quinoline and naphthyridine carboxylic acid antibacterials
IL142696A0 (en) Crystal modification a of 8-cyano-1-cyclopropyl-7-(1s,6s,-2, 8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
HUT75640A (en) Novel quinolone carboxylic acid derivatives
HK1104537A1 (en) Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8- diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
IL142837A0 (en) Semi-hydrochloride of 8-cyan-1-cycloproyl-7-(1s,6s-2,8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
PL349394A1 (en) Crystal modification d of 8-cyano-1-cyclopropyl-7- (1s, 6s- 2,8- diazabicyclo- [4.3.0] nonan-8-yl) -6-fluoro -1,4-dihydro -4-oxo -3-quinoline carboxylic acid
HUP0200006A2 (en) Crystal modification c of 8-cyano-1-cyclopropyl-7- (1s, 6s-2,8-diazabicyclo - [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid process for their preparation, pharmaceutical composition comprising thereof and their use
AU2002366092A1 (en) 1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides
ZA971507B (en) Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo(4.3.0)nonan-8-YL)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives.
AU1780800A (en) Process for the preparation of aromatic carboxylic acid amides
AU2325300A (en) Tricyclic quinolonecarboxylic acid derivatives or salts thereof
AU2691900A (en) 6-substituted-7- heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both
ZA200109823B (en) Process for the preparation of 1,8-disubstituted-1,3,4,9-tetrahydropyrano (3,4-b)-indole-1-acetic acid esters in a hydroxylic solvent.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed